All employers

Boehringer Ingelheim

Details

  • Number of employees
    50-100
  • Company Type
    Large Multi-national
About Boehringer Ingelheim

Boehringer Ingelheim is a global leader in the pharmaceutical industry, dedicated to researching, developing, and manufacturing innovative medicines that improve the health and quality of life for people and animals. Founded in 1885, the company has a rich history of commitment to scientific excellence and patient care.

With a strong focus on research and development, Boehringer Ingelheim invests heavily in discovering new therapies for diseases with high unmet medical needs. The company operates in various therapeutic areas, including respiratory diseases, cardiovascular health, oncology, and immunology.

In addition to human pharmaceuticals, Boehringer Ingelheim is also a prominent player in the animal health sector, providing vaccines and treatments that enhance the well-being of livestock and pets. This dual focus underscores the company’s vision of advancing health across species.

Boehringer Ingelheim is committed to sustainability and corporate social responsibility, striving to make a positive impact on society and the environment. The company actively engages in initiatives that promote access to healthcare and support local communities.

With a workforce of over 50,000 employees worldwide, Boehringer Ingelheim fosters a culture of innovation and collaboration, encouraging its teams to push the boundaries of science and technology. The company’s headquarters are located in Ingelheim am Rhein, Germany, but it has a significant presence in the UK, contributing to the local economy and healthcare landscape.

As a privately-owned company, Boehringer Ingelheim maintains a long-term perspective, allowing it to invest in research and development without the pressures of short-term financial performance. This approach enables the company to remain at the forefront of medical advancements and continue delivering value to patients and healthcare providers.

In summary, Boehringer Ingelheim is not just a pharmaceutical company; it is a partner in health, dedicated to improving lives through innovation, research, and a commitment to ethical practices.

>